Detalhe da pesquisa
1.
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Blood
; 141(7): 756-765, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327160
2.
Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis.
Am J Hematol
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606993
3.
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Br J Cancer
; 126(5): 797-803, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34949788
4.
Monoclonal gammopathy of undetermined significance.
Blood
; 133(23): 2484-2494, 2019 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010848
5.
Focal Liver Uptake on FDG PET/CT Without CT Correlate: Utility of MRI in the Evaluation of Patients With Known Malignancy.
AJR Am J Roentgenol
; 213(1): 175-181, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995099
6.
Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.
Nano Lett
; 18(4): 2195-2208, 2018 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29533667
7.
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma.
Ann Hematol
; 100(12): 3057-3060, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33009581
8.
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
Clin Immunol
; 158(1): 59-66, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805657
9.
Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.
Curr Neurol Neurosci Rep
; 15(1): 505, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394858
10.
Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma.
Blood Adv
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776397
11.
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
J Immunother Cancer
; 12(3)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448038
12.
Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives.
Crit Rev Oncol Hematol
; 187: 104040, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244325
13.
Outcomes with panobinostat in heavily pretreated multiple myeloma patients.
Semin Oncol
; 50(1-2): 40-48, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005144
14.
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support.
Bone Marrow Transplant
; 58(1): 80-86, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261708
15.
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Blood Adv
; 7(6): 1056-1064, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018226
16.
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance.
Cancer Cell
; 41(10): 1774-1787.e9, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774699
17.
Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.
Cancer Res Commun
; 3(12): 2560-2571, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019104
18.
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Cancer Discov
; 13(2): 348-363, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477267
19.
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths.
Cell Stem Cell
; 30(9): 1262-1281.e8, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582363
20.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
J Clin Oncol
; 41(21): 3712-3723, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192435